Dr. Martin Gleave awarded fourth annual Aubrey J. Tingle Prize

Date Posted: 

Dr. Martin Gleave, executive director of the Vancouver Prostate Centre, is the winner of the fourth annual Aubrey J. Tingle Prize. Created in honour of Michael Smith Foundation for Health Research’s founding president and CEO, this award is given to a British Columbia researcher whose work in health research is internationally recognized and has significant impact on advancing clinical or health services and policy research.

“Martin has contributed significantly to the understanding and treatment of prostate cancer, a disease that affects thousands of Canadian men every year,” says Dr. Diane Finegood, MSFHR president and CEO. “He has studied how prostate cancer grows on a cellular and molecular level and has used this research to develop therapies that specifically target these mechanisms, improving outcomes for men with the disease,” adds Finegood.

Further information is available at the Michael Smith Foundation for Health Research website.

A World Class Centre

The Vancouver Prostate Centre (VPC) has a track record of success that has earned it a reputation as one of the world’s most respected cancer facilities. It is a National Centre of Excellence and a designated Centre of Excellence for Commercialization and Research.


2016 Step Up team

Step Up Challenge fundraiser: February 25, 2018

The annual Step Up Challenge, raising funds for Prostate Cancer Canada, takes place in Vancouver on Sunday February 25. Click here to sponsor our relay team as they climbs 379 floors. Click here to volunteer to help with the event.

It's a Snow Day poster

It's A Snow Day at Mt. Seymour: March 9

Mt. Seymour is hosting It's A Snow Day, a fundraiser for Prostate Cancer Foundation BC, on Friday March 9. The event will include slope time, a reception, and a silent auction. Click here for more details including how to register, donate and/or sponsor.




Work at the Vancouver Prostate Centre

Thursday, January 18, 2018

Discovery of a promising new medication to block "master key" of cancer growth

Dr. Chris Ong
Tuesday, February 20, 2018

Drs. Wyatt and Chi: ctDNA predicts resistance to AR-targeted therapy

VCHRI News article on study of ctDNA predicting resistance to AR-targeted therapy

Make A Difference

Help the Vancouver Prostate Centre fund research to find better treatments and a cure.